Trial intelligence / Profile preview

ESPB vs PVB for Analgesia in MIDCAB

NCT05320718Completed

Sponsor
Peking University Third Hospital
Start
Apr 2022
Primary completion
Jun 2023
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised trial of ropivacaine in postoperative pain (2 arms), sponsored by Peking University Third Hospital. Primary endpoints: Pain at cough after surgery and Postoperative rescue analgesic consumption. Started Apr 2022; status: completed.

02

Drugs

ropivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05320718.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05320718.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call